These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 21695716)
1. shRNA-mediated silencing of Gli2 gene inhibits proliferation and sensitizes human hepatocellular carcinoma cells towards TRAIL-induced apoptosis. Zhang D; Liu J; Wang Y; Chen J; Chen T J Cell Biochem; 2011 Nov; 112(11):3140-50. PubMed ID: 21695716 [TBL] [Abstract][Full Text] [Related]
2. KLF6 transcription factor protects hepatocellular carcinoma-derived cells from apoptosis. Sirach E; Bureau C; Péron JM; Pradayrol L; Vinel JP; Buscail L; Cordelier P Cell Death Differ; 2007 Jun; 14(6):1202-10. PubMed ID: 17347668 [TBL] [Abstract][Full Text] [Related]
3. Selective down-regulation of glioma-associated oncogene 2 inhibits the proliferation of hepatocellular carcinoma cells. Kim Y; Yoon JW; Xiao X; Dean NM; Monia BP; Marcusson EG Cancer Res; 2007 Apr; 67(8):3583-93. PubMed ID: 17440069 [TBL] [Abstract][Full Text] [Related]
4. Gli2 silencing enhances TRAIL-induced apoptosis and reduces tumor growth in human hepatoma cells in vivo. Zhang DW; Li HY; Lau WY; Cao LQ; Li Y; Jiang XF; Yang XW; Xue P Cancer Biol Ther; 2014; 15(12):1667-76. PubMed ID: 25535898 [TBL] [Abstract][Full Text] [Related]
5. Gli2 upregulates cFlip and renders basal cell carcinoma cells resistant to death ligand-mediated apoptosis. Kump E; Ji J; Wernli M; Häusermann P; Erb P Oncogene; 2008 Jun; 27(27):3856-64. PubMed ID: 18264131 [TBL] [Abstract][Full Text] [Related]
6. DNMT1 and DNMT3b silencing sensitizes human hepatoma cells to TRAIL-mediated apoptosis via up-regulation of TRAIL-R2/DR5 and caspase-8. Kurita S; Higuchi H; Saito Y; Nakamoto N; Takaishi H; Tada S; Saito H; Gores GJ; Hibi T Cancer Sci; 2010 Jun; 101(6):1431-9. PubMed ID: 20398055 [TBL] [Abstract][Full Text] [Related]
7. Capsaicin sensitizes TRAIL-induced apoptosis through Sp1-mediated DR5 up-regulation: involvement of Ca(2+) influx. Moon DO; Kang CH; Kang SH; Choi YH; Hyun JW; Chang WY; Kang HK; Koh YS; Maeng YH; Kim YR; Kim GY Toxicol Appl Pharmacol; 2012 Feb; 259(1):87-95. PubMed ID: 22200406 [TBL] [Abstract][Full Text] [Related]
8. Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice. Zhang R; Ma L; Zheng M; Ren J; Wang T; Meng Y; Zhao J; Jia L; Yao L; Han H; Li K; Yang A Cancer Gene Ther; 2010 Apr; 17(4):275-88. PubMed ID: 19876077 [TBL] [Abstract][Full Text] [Related]
9. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2]. Xu JY; Chen LB; Xu JY; Yang Z; Wei HY; Xu RH Ai Zheng; 2006 May; 25(5):526-32. PubMed ID: 16687068 [TBL] [Abstract][Full Text] [Related]
10. Jak inhibitor induces S phase cell-cycle arrest and augments TRAIL-induced apoptosis in human hepatocellular carcinoma cells. Fuke H; Shiraki K; Sugimoto K; Tanaka J; Beppu T; Yoneda K; Yamamoto N; Ito K; Masuya M; Takei Y Biochem Biophys Res Commun; 2007 Nov; 363(3):738-44. PubMed ID: 17904524 [TBL] [Abstract][Full Text] [Related]
11. [Adeno-associated virus mediated tumor necrosis factor related apoptosis inducing ligand gene transfected into hepatocellular carcinoma cells by ultrasound microbubble intensifier: an experimental study]. Xia JT; Xu B; Wang SC; Lai YY; Wu ZF; Li SH; Li W Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1846-50. PubMed ID: 19040022 [TBL] [Abstract][Full Text] [Related]
12. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation. Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347 [TBL] [Abstract][Full Text] [Related]
13. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression. Yin J; Ding J; Huang L; Tian X; Shi X; Zhi L; Song J; Zhang Y; Gao X; Yao Z; Jing X; Yang J Anat Rec (Hoboken); 2013 Oct; 296(10):1568-75. PubMed ID: 23878061 [TBL] [Abstract][Full Text] [Related]
14. Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma. Kim JK; Jung KH; Noh JH; Eun JW; Bae HJ; Xie HJ; Ahn YM; Ryu JC; Park WS; Lee JY; Nam SW Int J Oncol; 2009 Dec; 35(6):1257-64. PubMed ID: 19885547 [TBL] [Abstract][Full Text] [Related]
15. 5, 7-Dimethoxyflavone sensitizes TRAIL-induced apoptosis through DR5 upregulation in hepatocellular carcinoma cells. Yang JF; Cao JG; Tian L; Liu F Cancer Chemother Pharmacol; 2012 Jan; 69(1):195-206. PubMed ID: 21660448 [TBL] [Abstract][Full Text] [Related]
16. Serum response factor depletion affects the proliferation of the hepatocellular carcinoma cells HepG2 and JHH6. Farra R; Dapas B; Pozzato G; Giansante C; Heidenreich O; Uxa L; Zennaro C; Guarnieri G; Grassi G Biochimie; 2010 May; 92(5):455-63. PubMed ID: 20144681 [TBL] [Abstract][Full Text] [Related]
17. Lentiviral-mediated Smad4 RNAi induced anti-proliferation by p16 up-regulation and apoptosis by caspase 3 down-regulation in hepatoma SMMC-7721 cells. Huang S; Zhang F; Miao L; Zhang H; Fan Z; Wang X; Ji G Oncol Rep; 2008 Nov; 20(5):1053-9. PubMed ID: 18949401 [TBL] [Abstract][Full Text] [Related]
18. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis. Yamanaka Y; Shiraki K; Inoue T; Miyashita K; Fuke H; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T Int J Mol Med; 2006 Jul; 18(1):41-7. PubMed ID: 16786154 [TBL] [Abstract][Full Text] [Related]
19. Survivin downregulation by siRNA/cationic liposome complex radiosensitises human hepatoma cells in vitro and in vivo. Yang W; Sun T; Cao J; Liu F Int J Radiat Biol; 2010 Jun; 86(6):445-57. PubMed ID: 20470195 [TBL] [Abstract][Full Text] [Related]
20. The cyclin-dependent kinase inhibitor flavopiridol sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis. Miyashita K; Shiraki K; Fuke H; Inoue T; Yamanaka Y; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T Int J Mol Med; 2006 Aug; 18(2):249-56. PubMed ID: 16820931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]